

Generative AI is poised to revolutionize drug discovery, with Eli Lilly and Nvidia predicting that AI will independently design novel drugs within a few years. Eli Lilly's experiments with AI have already yielded unique molecular designs that were initially met with skepticism but later acknowledged by scientists as innovative. This shift is part of a broader trend where AI's ability to 'think' differently is leading to creative breakthroughs in medicine, challenging traditional scientific methods and potentially increasing the success rate of drug development significantly.